Revance Therapeutics
RVNC
#7445
Rank
C$0.46 B
Marketcap
$4.43
Share price
0.65%
Change (1 day)
-60.97%
Change (1 year)

Revance Therapeutics (RVNC) - Total debt

Total debt on the balance sheet as of September 2024 : C$0.69 Billion

According to Revance Therapeutics's latest financial reports the company's total debt is C$0.69 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Revance Therapeutics - Total debt on balance sheet (from 2012 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$0.63 B11.75%
2022-12-31C$0.56 B37.3%
2021-12-31C$0.41 B52.92%
2020-12-31C$0.27 B605.78%
2019-12-31C$38.31 M
2018-12-31N/A-100%
2017-12-31C$2.35 M-67.25%
2016-12-31C$7.18 M-38.92%
2015-12-31C$11.76 M186.38%
2014-12-31C$4.1 M-84.86%
2013-12-31C$27.13 M-74.37%
2012-12-31C$0.10 B50.84%
2011-12-31C$70.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$0.28 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
C$51.30 B 7,295.02%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.54 B 1,275.72%๐Ÿ‡บ๐Ÿ‡ธ USA